Dave Bloom

764 POSTS 48 COMMENTS
CEO & Co-Founder of SnackSafely.com and proud food allergy dad. Advocating for food allergy awareness and causes since the founding of SnackSafely.com in 2011. Dedicated to solving issues critical to the food allergy community by leveraging over 25 years of technical expertise gained serving various senior roles in the Financial Services industry. Authority on issues regarding the manufacture of allergy-friendly food products and founder of the SnackSafely.com Manufacturer Partnership, a consortium of food manufacturers now numbering 75+ companies that have agreed to provide detailed disclosure of their manufacturing processes beyond what the FDA requires.
Panera Suit

Judge’s Ruling Paves Way for Jury Trial of Panera Peanut Butter Suit

Trial will have broad implications for the allergic community.
Allergence Profile

This Weekend’s Allergence Upgrade Brings Changes to Profiles

Upgrade promises a faster, more streamlined user experience.
Charlie from 'Hereditary'

Advisory: Disturbing Food Allergy Scene in ‘Hereditary’

Take special consideration before seeing this movie with young people coping with food allergies.
Perfect for Camp!

Tons of New Products in the Safe Snack Guide and Allergence!

Over 1000 peanut, tree nut and Top-8 allergen-free products, perfect for camp and activities!
Elijah Silvera

Elijah’s Legacy: NYC Daycares Required To Have Stock Epinephrine On-Hand

Rules adopted after child suffered fatal reaction from a grilled cheese sandwich.
The Roaring Silence (Apologies to Manfred Mann)

The Epinephrine Auto-Injector Shortage and the Roaring Silence

Hear that roar from the institutions tasked with keeping us safe and informed? No, we don't either.
AR101

Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages 4-55

Aimmune plans to submit a Biologics License Application for AR101 to the FDA by the end of 2018.
Divvies Benjamint Crunch Advisory

Advisory: Divvies Benjamint Crunch Recall

Important recall for those concerned with milk cross-contact.

Biomed Engineers Develop $80 Auto-Injector with $16 Epinephrine Refills

ZiBi Pen placed 2nd at the Design of Medical Devices Conference in April.
Lactobacillus rhamnosus

Enrollment Complete for Phase 2b Probiotic Oral Immunotherapy Treatment Candidate

Study to provide evidence of longer lasting tolerance to peanut in a larger number of patients.

Connect with Us

31,415FansLike
93FollowersFollow
4,821FollowersFollow
37SubscribersSubscribe